Back to search
Hidradenitis Suppurativa (HS)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Hidradenitis Suppurativa (HS) trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Hidradenitis Suppurativa (HS) trials you may qualify forThe purpose of this study is to evaluate the pharmacokinetics, safety, and efficacy of povorcitinib in adolescent participants with moderate to severe hidradeni…
Rollover study for participants from predetermined, Incyte-sponsored parent clinical trials of povorcitinib.
Primary purpose of the study is to assess the concentration of bimekizumab in mature human breast milk.
The purpose of this study is to learn about the safety and effects of the study medicine (called Ritlecitinib) for the possible treatment of hidradenitis suppur…
The purpose of this study is to assess efficacy, safety, pharmacokinetics and immunogenicity of subcutaneous SCT650C in patients with Moderate to Severe Hidrade…
The aim of this study is to generate real-world evidence to fill knowledge gaps regarding the response to secukinumab in patients with moderate to severe HS, it…
The purpose of the study is to evaluate the safety of long-term therapy of bimekizumab in study participants with moderate to severe hidradenitis suppurativa (H…
The purpose of the study is to characterize the challenges to physical activity and exercise for HS patients and design an exercise program (EP) with evidence-b…
The goal of this clinical trial is to learn if combining an IL-17A/F monoclonal antibody with non-ablative fractional laser therapy works and is safe in patient…